Bird flu: If or when? Planning for the next pandemic

Postgraduate Medical Journal

Volumn 83, Issue 981, 2007, Pages 445-450

  Sellwood, Chloe ^a   Asgari Jirhandeh, Nima ^a   Salimee, Sultan ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AVIAN INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR;

AVIAN INFLUENZA; DRUG SCREENING; HEALTH CARE PLANNING; HUMAN; INFLUENZA VIRUS A H5N1; INTERVENTION STUDY; MEDICAL EXPERT; PANDEMIC; POULTRY; REVIEW; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVIRAL AGENTS; BIRDS; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POULTRY DISEASES; WORLD HEALTH;

EID: 34547149482     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.059253     Document Type: Review

References (76)

1. Jordan WS Jr, Denny FW Jr, Badger GF, et al. A study of illness in a group of Cleveland families XVII. The occurrence of Asian influenza. Am J Hyg 1958;68:190-212.
2. Philip RN, Bell JA, Davies DJ, et al. Epidemiologic studies on influenza in familial and general population groups, 1951-1956. II. Characteristics of occurrence. Am J Hyg 1961;73:123-37.
3. Hall CE, Cooney MK, Fox JP. The Seattle virus watch. IV. Comparative epidemiologic observations of infections with influenza A and B viruses, 1965-1969, in families with young children. Am J Epidemiol 1973;98:365-80.
4. Dowdle WR, Coleman MT, Gregg MB. Natural history of influenza A in the United States, 1957-1972. Prog Med Virol 1974;17:91-135.
5. Monto AS, Kioumehr F. The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol 1975;102:553-63.
6. Pereira MS, Chakraverty P. The laboratory surveillance of influenza epidemics in the United Kingdom, 1968-1976. J Hyg Camb 1977;79:77-87.
7. Fox JP, Hall CE, Cooney MK, et al. Influenza virus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982;116:212-27.
8. Fleming DM, Crombie DL, Norbury CA, et al. Observations on the influenza epidemic of November-December 1989. Br J Gen Pract 1990;40:495-7.
9. Fleming DM. The impact of three influenza epidemics on primary care in England and Wales. Pharacoeconomics 1996;9(Suppl):38-45.
10. The Birmingham Research Unit of the Royal College of General Practitioners. Influenza:collective research in general practice. J R Coll Gen Pract 1977;27:544-51.
11. Hope-Simpson R-E. The role of season in the epidemiology of influenza. J Hyg Camb 1981;86:35-47.
12. Kilbourne ED. Influenza. New York: Plenum Medical Book Co, 1987.
13. Thacker SB. The persistence of influenza A in human populations. Epidemiol Rev 1986;8:129-41.
14. Cockburn WC, DElon PJ, Ferreira W. Origin and progress of the 1968-1969 Hong Kong influenza epidemic. Bull World Health Organ 1969;41:345-8.
15. Assad F, Cockburn WC, Sundaresan TK. Use of excess mortality from respiratory diseases in the study of influenza Bull World Health Organ 1973;49:219-33.
16. Hope-Simpson RE. First outbreak of Hong Kong influenza in a general practice population in Great Britain. A field and laboratory study. BMJ 1970;3:74-7.
17. Taubenberger JK, Reid AH, Krafft AE, et al. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 1997;275:1793-6.
18. Shope RE. Swine influenza. III. Filtration experiments and aetiology. J Exp Med 1931;54:373-80.
19. Chu CM, Shao C, Hou CC. Studies of strains of influenza virus isolated during the epidemic in 1957 in Changchun. Vop Virus, 1957;B, 278-81.
20. Chang WK. National influenza experiences in Hong Kong, 1968. Bull World Health Organ 1969;41:349-51.
21. Maurel N, Marine WM. Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man. Am J Epidemiol 1973;97:44-9.
22. Davenport FM. Reflections on the epidemiology of myxovirus infections. Med Microbiol Immunol 1977;163:69-76.
23. Rekart M, Rupnik K, Cesario TC, et al. Prevalence of hemagglutination inhibition antibody to current strains of the H3N2 and H1N1 subtypes of influenza: a virus in sera collected from the elderly in 1976. Am J Epidemiol 1982;115:587-97.
24. Masurel N, Heijink RA. Recycling of H1N1 influenza A virus in man - a haemagglutinin antibody study. J Hyg London 1983;90:397-402.
25. Davenport FM, Minuse E, Hennessy AV, et al. Interpretations of influenza antibody patterns of man. Bull World Health Organ 1969;41:4553-60.
26. Dowdle WR. Influenza A virus recycling revisted. Bull World Health Organ. 1999;77: 820-8, 1969;41:349-51.
27. Nguyen-Van-Tam JS, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine 2003;21:1762-8.
28. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell Scientific Publications, 1998:3-18.
29. Ashley j, Smith T, Dunnell K. Deaths in Great Britain associated with the influenza epidemic of 1989-1990. Popul Trends 1991;65:16-20.
30. Tillett HE, Smith JWG, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983;12:344-52.
31. Nguyen-Van-Tam JS. Epidemiology of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell Scientific Publications, 1998:181-206.
32. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell Scientific Publications, 1998:219-66.
33. HMSO. Supplement to the 81st annual report of the Registrar General: report on the mortality from influenza in England and Wales during the epidemic of 1918-1919. London: HMSO, 1920:1-47.
34. Dauer CC, Serfling RE. Mortality from influenza, 1957-1958 and 1959-1960. Am Rev Respir Dis 1961;83:15-28.
35. Alling DW, Blackwelder WC, Stuart-Harris H. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 1981;113:30-8.
36. Simonsen L, Schonberger LB, Stroup DF, et al. The impact of influenza on mortality in the USA. In: Brown LE, Hampson AW, Webster RG, eds. Options for the control of influenza III. Amsterdam: Elsevier, 1996:26-33.
37. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60.
38. Payne AMM. Symposium on the Asian influenza epidemic, 1957. Proc R Soc Med, 1958;51;1009-15.
39. Schoembaum SC, Coleman MT, Dowdle WR, et al. Epidemiology of influenza in the elderly: evidence of virus recycling. Am J Epidemiol 1976;103:166-7.
40. Gilsdorf A, Boxall N, Gasimov V, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Euro Surveill 2006;11:122-6.
41. Euro Surveillance. Tenth EU country detects highly pathogenic avian influenza in wild birds. Euro Surveill 2006;11:E060309.3.
42. Smith GJ, Naipospos TS, Nguyen TD, et al. Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology 2006;350:258-68.
43. World Health Organization Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005;11:1515-21.
44. Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:889-93.
45. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006;355:2186-94.
46. Normile D. Avian influenza. Human transmission but no pandemic in Indonesia. Science 2006;312:1855.
47. de Jong JC, Claas EC, Osterhaus ADME, et al. A pandemic warning? Nature 1997;389:554.
48. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-71.
49. Subbarao K, Shaw MW. Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev Med Virol 2000;10:337-48.
50. Claas EC, Osterhaus ADME, van Beek R, et al. Human influenza A H5N1 viruses related to a highly pathogenic avian influenza virus. Lancet 1998;351:472-7.
51. Centre for Disease Control. Update: isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, 1997-1998. MMWR Morb Mort Wkly Rep 1998;46:1245-7.
52. Webster RG, Hay AJ. The H5N1 influenza outbreak in Hong Long: a test of pandemic preparedness. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell Scientific Publications, 1998:561-5.
53. Buxton Bridges CB, Katz JM, Seto WH, et al. Risk of influenza A (H5N1) infection among healthcare workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000;181:344-8.
54. Editorial Team. Confirmed H5N1 avian influenza outbreak on a poultry farm in England, February 2007. Euro Surveill 2007;12:E070208.2.
55. World Health Organization Disease Outbreak News. Avian influenza A(H5N1) in humans and poultry in Viet Nam 2004 (13 January 2004). http://www.who.int/csr/don/2004_01_13/en/index.html (Accessed on 6 Dec 2006).
56. World Health Organization Disease Outbreak News. Avian influenza - situation in China - Update 13 (8 August 2006). http://www.who.int/csr/don/ 2006_08_08/en/index.html (Accessed on 6 Dec 2006).
57. Vong S, Coghlan B, Mardy S, et al. Low frequency of poultry-to-human H5N1 virus transmission, Southern Cambodia, 2005. Emerg Infect Dis. 2006;10, Available from http://www.cdc.gov/ncidod/EID/vol12no10/ 06-0424.htm.
58. Liem NT, Lim W. World Health Organization International Avian Influenza Investigation Team, Vietnam. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005;11:210-5.
59. Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis 2002;185:1005-10.
60. Thorson A, Petzold M, Nguyen TK, et al. Is exposure to sick or dead poultry associated with flulike illness? : a population-based study from a rural area in Vietnam with outbreaks of highly pathogenic avian influenza, Arch Intern Med 2006;166:119-23.
61. World Health Organization. WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before ana during pandemics, World Health Organization, Geneva, 2005. Document ref: WHO/CDS/CSR/GIP/2005, 5 http://www.who.int/csr/resources/publications/influenza/ GIP_2005_5Eweb.pdf (Accessed on 14 June 2007).
62. UK Department of Health and Cabinet Office. Pandemic influenza - a national framework for responding to an influenza pandemic. Draft for comment 2007. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_073185 (Accessed 12 April 2007).
63. Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006;368:886-9.
64. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 2006;367:1405-11.
65. Health Protection Agency. Health Protection Agency pandemic influenza contingency plan, 2006. http://www.hpa.org.uk/infections/ topics_az/influenza/pandemic/fluplan.htm (Accessed 6 Dec 2006).
66. Department of Health, Health Protection Agency. Guidance for pandemic innuenza: Infection control in hospitals and primary care settings, 2005. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en? CONTENT_ID=4121752&chk=lfHfV7 (Accessed 6 Dec 2006).
67. British Thoracic Society, British Infection Society, Health Protection Agency for the Department of Health. Clinical guidelines for patients with an influenza like illness during an influenza pandemic, 2006. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fsen? CONTENT_ID=4121753&chk=ZXKxus (Accessed 6 Dec 2006).
68. Homeland Security Council. National strategy for pandemic influenza: implementation plan, 2006 http://www.whitehouse.gov/homeland/ nspi_implementation.pdf (Accessed 6 Dec 2006).
69. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005;437:209-14.
70. Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. Nature 2006;442:448-52.
71. Cooper BS, Pitman RJ, Edmunds WJ, et al. Delaying the international spread of pandemic influenza. PLoS Med 2006;3:e212.
72. Pitman RJ, Cooper BS, Trotter CL, et al. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ 2005;331:1242-3.
73. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006;12:1657-62.
74. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003;37:1094-101.
75. Bell DM, WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006;12:81-7.
76. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53-80.